Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.033,76
1,00%
NASDAQ
20.017,89
-0,07%
Bitcoin
95.426,32
-3,90%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ bioAffinity Technologies Inc (BIAF) bioAffinity Technologies Inc (BIAF) Notizie

bioAffinity Technologies Inc

BIAF
0,9202
-0,0298 (-3,14%)
Ultimo aggiornamento: 19:57:28
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/12/202414:00BWJoin bioAffinity Technologies’ Exclusive Live Investor..
12/12/202414:00BWbioAffinity Technologies Set for Continued Expansion in 2025
05/12/202414:00BWVeterans’ Research Foundation Spotlights CyPath® Lung’s..
14/11/202414:00BWbioAffinity Technologies Reports $2.4 Million Revenue for Q3..
04/11/202414:00BWbioAffinity Technologies Appoints New Chief Science Officer..
30/10/202413:00BWbioAffinity Technologies Announces Award of Japanese Patent..
21/10/202417:39PRNUSWallachBeth Capital Announces Closing of bioAffinity..
21/10/202416:45BWbioAffinity Technologies Announces Closing of $2.6 Million..
18/10/202420:57PRNUSWallachBeth Capital Announces Pricing of bioAffinity..
18/10/202418:45BWbioAffinity Technologies Announces Pricing of $2.66 Million..
16/10/202414:00BWbioAffinity’s CyPath® Lung Cancer Test Supported by Newly..
10/10/202414:00BWbioAffinity Technologies Names J. Michael Edwards as Chief..
09/10/202414:00BWbioAffinity Technologies Awarded U.S. Federal Supply..
18/9/202414:00BWPeer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung..
26/8/202414:58IHMARKETNEWSIBM Closes China Research Division, Uber Fined $324M,..
23/8/202423:17EDGAR2Form PRE 14A - Other preliminary proxy statements
23/8/202423:15EDGAR2Form 8-K - Current report
23/8/202423:15BWbioAffinity Technologies CFO to Depart for New Opportunity;..
14/8/202422:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202422:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202415:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202415:25BWbioAffinity Technologies Reports $2.4 Million Revenue for Q2..
12/8/202422:00EDGAR2Form D - Notice of Exempt Offering of Securities
05/8/202420:00PRNUSWallachBeth Capital Announces Closing of bioAffinity..
05/8/202419:17BWbioAffinity Technologies Announces Closing of Registered..
05/8/202415:03EDGAR2Form 8-K - Current report
05/8/202415:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/8/202416:00PRNUSWallachBeth Capital Announces bioAffinity Technologies..
02/8/202415:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/8/202415:25BWbioAffinity Technologies Announces Pricing of Registered..
09/7/202422:30EDGAR2Form 8-K - Current report
09/7/202414:00BWbioAffinity Technologies Reports 217% Sales Growth in Second..
12/6/202414:00BWbioAffinity Technologies Reports Accelerating Growth of..
15/5/202415:15BWbioAffinity Technologies Reports Record Q1 Revenue Driven by..
02/5/202414:00BWbioAffinity Technologies News Update
24/4/202414:00BWbioAffinity Technologies Advances New Product Development..
09/4/202414:00BWbioAffinity Technologies Expands Campaign to Support..
01/4/202415:49BWbioAffinity Technologies Reports Fourth Quarter and Full..
08/3/202423:00EDGAR2Form 8-K - Current report
08/3/202419:15PRNUSWallachbeth Capital Announces Closing of bioAffinity..
08/3/202418:45BWbioAffinity Technologies Announces Closing of $2.5 Million..
08/3/202418:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/3/202403:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/3/202416:45PRNUSWallachBeth Capital Announces Pricing of BioAffinity..
06/3/202415:46BWbioAffinity Technologies Announces Pricing of $2.5 Million..
05/3/202423:26EDGAR2Form 8-K - Current report
05/3/202414:00BWbioAffinity Technologies Reports Accelerating Sales Growth..
21/2/202414:00BWbioAffinity Technologies News Update
06/2/202414:00BWMedical Director of Lung Innovations Network and The Lung..
02/2/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,01 Min: 0,91 Max: 1,01
Chiusura: 0,95

La tua Cronologia

NASDAQ
BIAF
bioAffinity Technologies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network